Dramatic ruxolitinib efficacy in chronic enteropathy associated with SLCO2A1 gene (CEAS).

MLA

Ricard, Laure, et al. “Dramatic Ruxolitinib Efficacy in Chronic Enteropathy Associated with SLCO2A1 Gene (CEAS).” Journal of Digestive Diseases, vol. 25, no. 8, Aug. 2024, pp. 537–39. EBSCOhost, https://doi.org/10.1111/1751-2980.13309.

APA

Ricard, L., Charbit-Henrion, F., Courties, A., Mohty, M., Legrand, O., Benady, V., Bourrier, A., Baujat, G., & Malard, F. (2024). Dramatic ruxolitinib efficacy in chronic enteropathy associated with SLCO2A1 gene (CEAS). Journal of Digestive Diseases, 25(8), 537–539. https://doi.org/10.1111/1751-2980.13309

Chicago

Ricard, Laure, Fabienne Charbit-Henrion, Alice Courties, Mohamad Mohty, Ollivier Legrand, Victor Benady, Anne Bourrier, Geneviève Baujat, and Florent Malard. 2024. “Dramatic Ruxolitinib Efficacy in Chronic Enteropathy Associated with SLCO2A1 Gene (CEAS).” Journal of Digestive Diseases 25 (8): 537–39. doi:10.1111/1751-2980.13309.